The Arbidol Story: How a Clinically Used Antiviral Drug Inhibits Hepatitis C, Ebola, and Zika Virus

The Arbidol Story: How a Clinically Used Antiviral Drug Developed for Influenza Virus Inhibits Hepatitis C, Ebola, and Zika Virus Globally, annual viral epidemics and outbreaks cause millions of cases of severe illness, and hundreds of thousands of deaths. There is a continuing need for development of antiviral drugs that provide effective, affordable, orally administered, and safe approaches to preventing the devastating effects of viruses that cause significant morbidity and mortality, that frequently re